Goldman Sachs Group Inc Tiziana Life Sciences LTD Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 21,460 shares of TLSA stock, worth $36,482. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,460Holding current value
$36,482% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding TLSA
# of Institutions
33Shares Held
4.06MCall Options Held
32KPut Options Held
0-
Dauntless Investment Group, LLC Commerce Township, MI2.74MShares$4.65 Million4.04% of portfolio
-
Marshall Wace, LLP London, X0268KShares$455,6200.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny241KShares$409,3830.0% of portfolio
-
Morgan Stanley New York, NY97.1KShares$165,0730.0% of portfolio
-
Zhang Financial LLC84.2KShares$143,1400.01% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $174M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...